United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.55, $1.20 better than the analyst estimate of $2.35. Revenue for the quarter came in at $386.2 million versus the consensus estimate of $363.5 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.

Earnings

Cowen Remains Bullish on United Therapeutics (UTHR) as Orenitram Continues to Grow October 27, 2015 4:01 PM Leerink Partners Reiterates Market Perform Following United Therapeutics (UTHR) 3Q beat October 27, 2015 1:44 PM Form 10-Q UNITED THERAPEUTICS Corp For: Sep 30October 27, 2015 6:09 AM Form 8-K UNITED THERAPEUTICS Corp For: Oct 27October 27, 2015 6:08 AM United Therapeutics Corporation Reports Third Quarter 2015 Financial ResultsOctober 27, 2015 6:00 AM